this has generated renewed interest in the highly complex pharmacokinetic and pharmacodynamic properties of levodopa , with the aim of reducing fluctuations in plasma levodopa ( and hence brain dopamine ) concentrations by sustained release oral or continuous parenteral administration of the drug .
C0543488
interest
C0006104
brain